Overview
GBS screening detects maternal colonization with Streptococcus agalactiae using enriched culture and/or molecular methods from combined vaginal-rectal swabs.
Clinical Importance
Identify pregnant patients who need intrapartum antibiotic prophylaxis
Reduce early-onset neonatal GBS disease risk per obstetric guidelines
Specimen Requirements
- Specimen: combined lower vaginal and rectal swab (not cervical)
- Timing: typically late pregnancy per current obstetric guidance (commonly 36 0/7–37 6/7 weeks; verify current guideline)
- Transport: Amies or validated molecular collection device
Analytical Method
Swabs are incubated in selective enrichment broth (e.g., Lim broth) then subcultured to blood agar / chromogenic media, or tested by NAAT from enrichment or direct protocols. Isolates are identified as S. agalactiae.
Instruments Used
Automated analyzers
- Molecular GBS assay platforms (selected laboratories)
- MALDI-TOF identification of isolates
Manual methods
- Lim broth enrichment with subculture and CAMP/MALDI identification
Reference Values
Microbiology results are interpreted against organism identification, specimen quality, clinical context, and current CLSI and/or EUCAST interpretive criteria (including CLSI M100 for susceptibility where adopted). Reporting conventions and critical-notification lists are institution-defined; verify against the performing laboratory SOP and current guideline editions.
Expected: GBS not detected. Colonization status can change; timing of collection matters.
Interpretation
Common Causes of Increased Results
- GBS detected; report for obstetric prophylaxis pathways
Common Causes of Decreased Results
- GBS not detected; prophylaxis may still be indicated for other obstetric risk factors per guidelines
Clinical Significance
- Routine antenatal GBS screening
- Intrapartum risk-based decisions when screening results are available
Factors Affecting Results
Pre-analytical
- Cervical-only swab instead of vaginal-rectal
- Collection outside recommended gestational window
Analytical
- Skipping enrichment step in culture protocols
Post-analytical
- Failing to communicate results into obstetric records promptly
Advantages and Limitations
Advantages
- Evidence-based prevention laboratory test
- Enrichment improves yield
Limitations
- Colonization can be intermittent
- Does not replace clinical risk assessment when results are missing
Clinical Pearls
If the swab never touched rectum, your 'GBS-negative' screen may be a sampling miss.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Carroll KC, Pfaller MA, Landry ML, et al., eds. Manual of Clinical Microbiology. ASM Press (verify current edition).
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2020.
- Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology. 6th ed. Elsevier; 2018.
- Carroll KC, Hobden JA, Miller S, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology. 28th ed. McGraw-Hill; 2019.
- Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 9th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100 (verify current edition and institutional adoption).
- Centers for Disease Control and Prevention / NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL). Current edition (verify institutional adoption).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance relevant to clinical microbiology practice (verify current WHO publication for the method).
Frequently Asked Questions
Common questions about using this Group B Streptococcus Screen laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Group B Streptococcus Screen laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Group B Streptococcus Screen. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Group B Streptococcus Screen specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Group B Streptococcus Screen. Confirm collection details against your laboratory protocol.
Where are Group B Streptococcus Screen reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Group B Streptococcus Screen results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Group B Streptococcus Screen?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Group B Streptococcus Screen?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Group B Streptococcus Screen?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Medical Microbiology topic.
What are the clinical pearls for Group B Streptococcus Screen?
See the Clinical Pearls section for concise laboratory practice notes associated with Group B Streptococcus Screen. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.